Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Discovery of acyl ureas as highly selective small molecule CSF1R kinase inhibitors

Journal Article · · Bioorg. Med. Chem. Lett.

Research Organization:
Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)
Sponsoring Organization:
DOE - Office Of Science; INDUSTRY
OSTI ID:
1900946
Journal Information:
Bioorg. Med. Chem. Lett., Journal Name: Bioorg. Med. Chem. Lett. Vol. 74
Country of Publication:
United States
Language:
ENGLISH

References (20)

Colony-stimulating factor-1 in immunity and inflammation journal February 2006
A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells journal January 2006
Dynamic architecture of a protein kinase journal October 2014
CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice journal August 2019
Colony-stimulating factors in inflammation and autoimmunity journal July 2008
Differential Effects of CSF-1R D802V and KIT D816V Homologous Mutations on Receptor Tertiary Structure and Allosteric Communication journal May 2014
Tumor-Associated Macrophages: From Mechanisms to Therapy journal July 2014
Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer’s-like pathology journal January 2016
Trophic macrophages in development and disease journal April 2009
JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia journal November 2009
Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegeneration journal December 2019
Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma Viability journal February 2020
Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants journal May 2019
Small-Molecule CSF1R Inhibitors as Anticancer Agents journal July 2020
Beyond T Cells: Understanding the Role of PD-1/PD-L1 in Tumor-Associated Macrophages journal November 2019
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial journal August 2019
The M-CSF receptor in osteoclasts and beyond journal August 2020
Protein kinases: evolution of dynamic regulatory proteins journal February 2011
PD-L1+ tumor-associated macrophages and PD-1+ tumor-infiltrating lymphocytes predict survival in primary testicular lymphoma journal July 2018
Tumour-associated macrophages as treatment targets in oncology journal January 2017

Similar Records

Fragment-based discovery of a small molecule inhibitor of Bruton’s Tyrosine Kinase
Journal Article · Thu Jul 02 00:00:00 EDT 2015 · Journal of Medicinal Chemistry · OSTI ID:1213735

Discovery of Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic
Journal Article · Mon Dec 31 23:00:00 EST 1984 · ACS Med. Chem. Lett. · OSTI ID:1867449

Discovery of Diverse Small-Molecule Inhibitors of Mammalian Sterile20-like Kinase 3 (MST3)
Journal Article · Mon May 02 00:00:00 EDT 2016 · ChemMedChem(Print) · OSTI ID:1257469

Related Subjects